BusinessAdvancing Precision Medicine Through Pharmacogenetics Updated Test Prevents Adverse Drug ReactionsBy Nasdaq OMXFeb 10, 2016, 11:05 PM UTC
BusinessMetabolix to Provide Company Update at Source Capital ConferenceBy Nasdaq OMXFeb 10, 2016, 2:05 PM UTC
BusinessAmicus Therapeutics Announces Presentations and Posters at 12th Annual WORLDSymposium™ 2016By Nasdaq OMXFeb 10, 2016, 12:30 PM UTC
BusinessAdvancing Precision Medicine Through Pharmacogenetics Updated Test Prevents Adverse Drug ReactionsBy Nasdaq OMXFeb 9, 2016, 5:11 PM UTC
BusinessAmedica Regains Compliance With Nasdaq Listing Requirements and Announces Capitalization ImprovementsBy Nasdaq OMXFeb 9, 2016, 2:15 PM UTC
BusinessBioRestorative Therapies Names Lead Cell-Based Lumbar Disc Therapeutic ProductBy Nasdaq OMXFeb 9, 2016, 1:00 PM UTC
BusinessAlder BioPharmaceuticals Strengthens and Expands Leadership Team Supporting Advancement of ALD403 Toward Future CommercializationBy Nasdaq OMXFeb 9, 2016, 1:00 PM UTC
BusinessZIOPHARM Announces First Patient Enrolled in Phase 1 Study of Second Generation Non-Viral CD19-Specific CAR T-Cell Therapy for Advanced Lymphoid MalignanciesBy Nasdaq OMXFeb 9, 2016, 12:00 PM UTC
